Chika Kikuchi

Title: Chika Kikuchi and T-Cell Activation Innovation.

Introduction

Chika Kikuchi is an inventor associated with Scripps Research Institute in San Diego, California. Her patent work focuses on approaches to enhance T-cell activation and expansion, with potential applications in stimulating immune responses.

Latest Patents

Kikuchi is named on 1 patent: “Disruption of CD28-Sialoside Ligand Complexes to Enhance T Cell Activation.” The invention describes methods using a targeting agent-enzyme conjugate. The conjugate combines a targeting moiety that binds a cell-surface molecule on T cells with a sialidase, or an enzymatically active fragment of one. The patent also describes therapeutic conjugates, including combinations of sialidase and a T-cell-targeting antibody, such as an anti-PD1 antibody.

Career Highlights

Kikuchi’s listed patent connects targeted enzyme activity with T-cell immune response research. The disclosed methods are intended to support T-cell activation and expansion.

Collaborations

The patent’s listed collaborators include James C. Paulson and Landon J. Edgar. The work is associated with Scripps Research Institute.

Conclusion

Chika Kikuchi’s patent highlights a targeted approach to modulating T-cell activity, reflecting research at the intersection of enzyme-based methods and immune-response innovation.